Latest Insider Transactions at Centene Corp (CNC)
This section provides a real-time view of insider transactions for Centene Corp (CNC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CENTENE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CENTENE CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2022
|
Brandy Burkhalter EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,977
-0.84%
|
$244,114
$82.46 P/Share
|
|
Mar 24
2022
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3,690
-2.34%
|
$302,580
$82.71 P/Share
|
|
Mar 24
2022
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,977
-1.86%
|
$244,114
$82.46 P/Share
|
|
Mar 24
2022
|
Shannon Bagley EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,044
-2.18%
|
$249,608
$82.46 P/Share
|
|
Mar 24
2022
|
Brent D Layton President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,977
-0.55%
|
$244,114
$82.46 P/Share
|
|
Mar 15
2022
|
Colin A Toney EVP, Mergers & Acquisitions |
SELL
Payment of exercise price or tax liability
|
Direct |
947
-1.72%
|
$79,548
$84.33 P/Share
|
|
Mar 15
2022
|
Katie Casso Corporate Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
530
-1.44%
|
$44,520
$84.33 P/Share
|
|
Mar 11
2022
|
Katie Casso Corporate Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
4,737
+11.43%
|
$397,908
$84.44 P/Share
|
|
Mar 02
2022
|
Andrew Lynn Asher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,227
-0.86%
|
$184,841
$83.15 P/Share
|
|
Feb 28
2022
|
Sarah London Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,600
-1.08%
|
$215,800
$83.52 P/Share
|
|
Feb 07
2022
|
Leslie V Norwalk Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+50.0%
|
-
|
|
Feb 07
2022
|
Wayne S De Veydt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+50.0%
|
-
|
|
Feb 07
2022
|
Theodore R. Samuels Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+50.0%
|
-
|
|
Feb 07
2022
|
Kenneth A Burdick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+0.28%
|
-
|
|
Feb 07
2022
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+50.0%
|
-
|
|
Jan 23
2022
|
Andrew Lynn Asher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,324
-0.89%
|
$178,948
$77.14 P/Share
|
|
Jan 21
2022
|
Kenneth A Burdick Director |
SELL
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
179,000
-67.42%
|
$13,425,000
$75.0 P/Share
|
|
Jan 20
2022
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
2,774
-1.7%
|
$221,920
$80.0 P/Share
|
|
Jan 11
2022
|
David P Thomas CEO, Markets and Medicaid |
SELL
Open market or private sale
|
Direct |
4,000
-4.64%
|
$308,000
$77.61 P/Share
|
|
Dec 31
2021
|
Tommy G Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
450
+0.2%
|
-
|
|
Dec 31
2021
|
H James Dallas Director |
BUY
Grant, award, or other acquisition
|
Direct |
426
+1.57%
|
-
|
|
Dec 31
2021
|
William L Trubeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
426
+0.46%
|
-
|
|
Dec 31
2021
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
426
+0.13%
|
-
|
|
Dec 31
2021
|
John R Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
426
+0.22%
|
-
|
|
Dec 31
2021
|
Robert K Ditmore Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+0.08%
|
-
|
|
Dec 22
2021
|
Brent D Layton President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,730
-0.69%
|
$305,860
$82.99 P/Share
|
|
Dec 21
2021
|
Colin A Toney EVP, Mergers & Acquisitions |
SELL
Open market or private sale
|
Direct |
2,807
-4.85%
|
$230,174
$82.94 P/Share
|
|
Dec 15
2021
|
Colin A Toney EVP, Mergers & Acquisitions |
BUY
Grant, award, or other acquisition
|
Direct |
22,743
+28.2%
|
$1,842,183
$81.85 P/Share
|
|
Dec 15
2021
|
Andrew Lynn Asher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,155
+10.61%
|
$2,523,555
$81.85 P/Share
|
|
Dec 15
2021
|
Andrew Lynn Asher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,624
-1.12%
|
$212,544
$81.85 P/Share
|
|
Dec 15
2021
|
Brent D Layton President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
45,795
+4.03%
|
$3,388,830
$74.04 P/Share
|
|
Dec 15
2021
|
Brent D Layton President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,243
-4.87%
|
$2,125,683
$81.85 P/Share
|
|
Dec 15
2021
|
Brandy Burkhalter EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
28,746
-7.52%
|
$2,328,426
$81.85 P/Share
|
|
Dec 15
2021
|
Brandy Burkhalter EVP |
BUY
Grant, award, or other acquisition
|
Direct |
17,568
+4.39%
|
$1,159,488
$66.23 P/Share
|
|
Dec 15
2021
|
Sarah London Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,155
+11.46%
|
$2,523,555
$81.85 P/Share
|
|
Dec 15
2021
|
Sarah London Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,984
-1.4%
|
$241,704
$81.85 P/Share
|
|
Dec 15
2021
|
Christopher Koster Secretary & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
42,203
+12.0%
|
$3,123,022
$74.04 P/Share
|
|
Dec 15
2021
|
Christopher Koster Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
10,378
-8.36%
|
$840,618
$81.85 P/Share
|
|
Dec 15
2021
|
Mark J Brooks EVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,947
+7.09%
|
$1,846,078
$74.04 P/Share
|
|
Dec 15
2021
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,278
-8.82%
|
$1,156,518
$81.85 P/Share
|
|
Dec 15
2021
|
David P Thomas CEO, Markets and Medicaid |
BUY
Grant, award, or other acquisition
|
Direct |
15,577
+15.3%
|
$1,261,737
$81.85 P/Share
|
|
Dec 15
2021
|
David P Thomas CEO, Markets and Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
1,492
-2.07%
|
$120,852
$81.85 P/Share
|
|
Dec 15
2021
|
Orlando Ayala Director |
SELL
Open market or private sale
|
Direct |
7,586
-9.2%
|
$622,052
$82.99 P/Share
|
|
Dec 15
2021
|
Michael F Neidorff Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
230,720
+1.74%
|
$17,073,280
$74.13 P/Share
|
|
Dec 15
2021
|
Michael F Neidorff Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
117,183
-1.81%
|
$9,491,823
$81.85 P/Share
|
|
Dec 14
2021
|
Katie Casso Corporate Controller & CAO |
SELL
Open market or private sale
|
Direct |
8,000
-20.01%
|
$632,000
$79.19 P/Share
|
|
Dec 14
2021
|
Michael F Neidorff Chairman & CEO |
SELL
Open market or private sale
|
Direct |
50,000
-0.39%
|
$3,950,000
$79.74 P/Share
|
|
Dec 12
2021
|
Michael F Neidorff Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,472
-0.22%
|
$1,128,816
$78.45 P/Share
|
|
Dec 11
2021
|
Brandy Burkhalter EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
3,580
-0.97%
|
$279,240
$78.45 P/Share
|
|
Dec 11
2021
|
David P Thomas CEO, Markets and Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
1,239
-1.69%
|
$96,642
$78.45 P/Share
|